ATE230260T1 - Therapeutische abgabesysteme und verfahren für ihre verwendung - Google Patents
Therapeutische abgabesysteme und verfahren für ihre verwendungInfo
- Publication number
- ATE230260T1 ATE230260T1 AT94931827T AT94931827T ATE230260T1 AT E230260 T1 ATE230260 T1 AT E230260T1 AT 94931827 T AT94931827 T AT 94931827T AT 94931827 T AT94931827 T AT 94931827T AT E230260 T1 ATE230260 T1 AT E230260T1
- Authority
- AT
- Austria
- Prior art keywords
- approximately
- c2h4o
- methods
- c3h6o
- integer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13827193A | 1993-10-15 | 1993-10-15 | |
PCT/US1994/011594 WO1995010265A1 (en) | 1993-10-15 | 1994-10-12 | Therapeutic delivery compositions and methods of use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE230260T1 true ATE230260T1 (de) | 2003-01-15 |
Family
ID=22481270
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT94931827T ATE230260T1 (de) | 1993-10-15 | 1994-10-12 | Therapeutische abgabesysteme und verfahren für ihre verwendung |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0723440B1 (de) |
JP (1) | JP3819422B2 (de) |
KR (1) | KR100218140B1 (de) |
AT (1) | ATE230260T1 (de) |
AU (1) | AU8076494A (de) |
DE (1) | DE69431959T2 (de) |
DK (1) | DK0723440T3 (de) |
ES (1) | ES2189808T3 (de) |
WO (1) | WO1995010265A1 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1181937A3 (de) | 1994-08-09 | 2004-02-04 | Cytrx Corporation | Nukleinsäure enthaltender Impfstoff, Impfstoff-adjuvans |
US5656611A (en) * | 1994-11-18 | 1997-08-12 | Supratek Pharma Inc. | Polynucleotide compositions |
US6040295A (en) | 1995-01-13 | 2000-03-21 | Genemedicine, Inc. | Formulated nucleic acid compositions and methods of administering the same for gene therapy |
US5789244A (en) | 1996-01-08 | 1998-08-04 | Canji, Inc. | Compositions and methods for the treatment of cancer using recombinant viral vector delivery systems |
US7002027B1 (en) | 1996-01-08 | 2006-02-21 | Canji, Inc. | Compositions and methods for therapeutic use |
US6392069B2 (en) | 1996-01-08 | 2002-05-21 | Canji, Inc. | Compositions for enhancing delivery of nucleic acids to cells |
US6673914B1 (en) | 1998-01-22 | 2004-01-06 | John Wayne Cancer Institute | Human tumor-associated gene |
KR100360827B1 (ko) | 1999-08-14 | 2002-11-18 | 주식회사 삼양사 | 난용성 약물을 가용화하기 위한 고분자 조성물 및 그의 제조방법 |
CA2407074A1 (en) | 2000-04-21 | 2001-11-01 | Jukka Hartikka | Compositions and methods for in vivo delivery of polynucleotide-based therapeutics |
EP1232758A1 (de) * | 2001-02-19 | 2002-08-21 | Aventis Pasteur | Polynukleotid-Formulierung für verbesserte intrazellulare Übertragung |
JP4727923B2 (ja) | 2001-12-20 | 2011-07-20 | シェーリング コーポレイション | Syn3組成物およびその方法 |
CN101396555A (zh) | 2003-06-04 | 2009-04-01 | 坎基股份有限公司 | 用于干扰素治疗的方法和组合物 |
DK3311824T3 (da) | 2013-02-05 | 2020-04-14 | Univ Leland Stanford Junior | Cd47 målrettede terapier til behandlingen af infektionssygdomme |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3308458A1 (de) * | 1983-03-10 | 1984-09-13 | Behringwerke Ag, 3550 Marburg | Verfahren zur adjuvierung von vaccinen |
IT1191608B (it) * | 1985-02-01 | 1988-03-23 | Zambon Spa | Composizione farmaceutica e forme farmaceutiche che la contengono |
AU6334586A (en) * | 1986-05-15 | 1987-12-01 | Emory University | Composition and method for treating a thrombus and embolus |
US5037644A (en) * | 1986-10-27 | 1991-08-06 | Cetus Corporation | Pharmaceutical compositions of recombinant interleukin-2 and formulation processes |
US5221495A (en) * | 1990-04-13 | 1993-06-22 | Colgate-Palmolive Company | Enzyme stabilizing composition and stabilized enzyme containing built detergent compositions |
DE69230372T2 (de) * | 1991-03-19 | 2000-06-15 | Cytrx Corp | Polyoxypropylen/polyoxyethylen copolymere mit verbesserter biologischer aktivität |
AU3129993A (en) * | 1991-11-08 | 1993-06-07 | Massachusetts Institute Of Technology | Localized oligonucleotide therapy |
-
1994
- 1994-10-12 ES ES94931827T patent/ES2189808T3/es not_active Expired - Lifetime
- 1994-10-12 KR KR1019960701930A patent/KR100218140B1/ko not_active IP Right Cessation
- 1994-10-12 AU AU80764/94A patent/AU8076494A/en not_active Abandoned
- 1994-10-12 EP EP19940931827 patent/EP0723440B1/de not_active Expired - Lifetime
- 1994-10-12 AT AT94931827T patent/ATE230260T1/de not_active IP Right Cessation
- 1994-10-12 JP JP51203195A patent/JP3819422B2/ja not_active Expired - Fee Related
- 1994-10-12 DE DE1994631959 patent/DE69431959T2/de not_active Expired - Fee Related
- 1994-10-12 DK DK94931827T patent/DK0723440T3/da active
- 1994-10-12 WO PCT/US1994/011594 patent/WO1995010265A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR960704534A (ko) | 1996-10-09 |
WO1995010265A1 (en) | 1995-04-20 |
EP0723440A1 (de) | 1996-07-31 |
JP3819422B2 (ja) | 2006-09-06 |
AU8076494A (en) | 1995-05-04 |
DE69431959D1 (de) | 2003-02-06 |
KR100218140B1 (ko) | 1999-09-01 |
EP0723440B1 (de) | 2003-01-02 |
DK0723440T3 (da) | 2003-02-24 |
ES2189808T3 (es) | 2003-07-16 |
JPH09503788A (ja) | 1997-04-15 |
DE69431959T2 (de) | 2003-11-06 |
EP0723440A4 (de) | 1997-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE230260T1 (de) | Therapeutische abgabesysteme und verfahren für ihre verwendung | |
EP0677056B1 (de) | Olionukleotidalkylphosphonate und -phosphonothioate | |
US20020137718A1 (en) | Nucleozymes | |
FI946201A0 (fi) | Itsestabiloidut oligonukleotidit terapeuttisina aineina | |
KR100310277B1 (ko) | 뼈 형성 촉진용 저분자량 하이알루론산의 제조 | |
BR9106729A (pt) | Composto,processos para inibir a degradacao por nuclease de compostos e para estabilizar sequencias de nicleotideos ou oligonucleosideos,composicao utilizavel para inibir expressao de genes e processo para inibir expressao de genes em um mamifero necessitando de tal tratamento | |
DE59606352D1 (de) | Reinigungsmittel für harte oberflächen | |
KR920702383A (ko) | 치료제의 방출을 조절하는데 유용한 생부식성 중합체 | |
JP2004536103A5 (de) | ||
MX9406552A (es) | Metodo, composiciones y dispositivos para la admi nistracion de polinucleotidos desnudos que codifi can peptidos biologicamente activos. | |
US6040159A (en) | TNF-α ribozymes and derivatives capable of decreasing degradation of MRNA in vivo | |
CA2377290A1 (en) | Utilization of a highly fluorinated oligomeric alkane in ophthalmology | |
WO2002062767A1 (fr) | Nouveaux derives de quinazoline | |
CA2132265C (en) | Anti-sense oligonucleotides against hsv-1, and their preparation | |
FR2790757B1 (fr) | Oligonucleotides contenant une sequence antisens stabilises par une structure secondaire et compositions pharmaceutiques les contenant. | |
HUP0002683A2 (hu) | Terápiás anyagok sejtekhez való eljuttatásának fokozására szolgáló készítmények és módszerek | |
HUP0103751A2 (hu) | Epesavval helyettesített fenilalkenoilguanidinek, valamint e vegyületeket tartalmazó gyógyászati készítmények és eljárás ezek előállítására | |
WO1996019478A1 (en) | 6'-substituted carbocyclic nucleosides | |
KR20200024793A (ko) | 알파-ENaC의 발현을 억제하기 위한 RNAi 작용제 및 사용 방법 | |
HUP0100559A2 (hu) | Alkoxilezett alifás aminok alkalmazása, ilyen aminokat tartalmazó savas tisztítókompozíció és eljárás felületek fertőtlenítésére | |
WO2001098522A3 (en) | Positively-charged peptide nucleic acid analogs with improved properties | |
CA2174122A1 (en) | Therapeutic delivery compositions and methods of use thereof | |
AU3881095A (en) | Double-stranded oligonucleotide and carcinostatic agent containing the same as active ingredient | |
WO2005039480A8 (en) | AChE ANTISENSE DEOXYOLIGONUCLEOTIDE AS AN ANTI-INFLAMMATORY AGENT | |
EP0129891A3 (de) | Chinazolinon-Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0723440 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |